April 2018

Trending on OncLive

VOLGA, DASL-HiCaP Data Highlight Key Genitourinary Cancer Presentations Arriving at ESMO 2026

Stay Ahead of ESMO 2026: See What Lung Cancer Experts Are Prioritizing

CHMP Recommends Approval of Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer

Talquetamab Plus Daratumumab Earns CHMP Backing in R/R Myeloma

Lifileucel Linked to Low Rates of Post-Discharge Severe TRAEs, Readmissions in Advanced Melanoma